Amanote Research
Register
Sign In
Figure 5: MEG3 Inhibited the Activation of WNT/Β-Catenin Signaling in Podocytes.
doi 10.7717/peerj.8016/fig-5
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
PeerJ
Related search
Figure 6: MEG3 Inhibited Podocyte Injury by Inhibiting WNT/Β-Catenin Signaling.
Long Noncoding RNA MEG3 Suppresses Podocyte Injury in Diabetic Nephropathy by Inactivating WNT/Β-Catenin Signaling
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Activation of the WNT/Β-Catenin Signaling Pathway Causes Radioresistance in Colon Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Novel Β-Carbolines Inhibit WNT/Β-Catenin Signaling
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Figure 3: VB-1 Promotes WNT/Β-Catenin Signaling in Human DPCs.
Dysregulation of WNT/Β-Catenin Signaling in Gastrointestinal Cancers
Gastroenterology
Hepatology
Gastroenterology
WNT/Β-Catenin Signaling: Components, Mechanisms, and Diseases
Developmental Cell
Biochemistry
Developmental Biology
Genetics
Cell Biology
Molecular Biology
CUL4B Promotes Aggressive Phenotypes of HNSCC via the Activation of the WNT/Β‐catenin Signaling Pathway
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Regulation of WNT/Β-Catenin Signaling by Posttranslational Modifications
Cell and Bioscience
Biochemistry
Genetics
Molecular Biology
